Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored VaccinesLynda Coughlan(University of Maryland, Baltimore)Frontiers in ImmunologyMay 19, 202010.3389/fimmu.2020.00909Cited by 133SaveCiteExport RISWatch citationsRelated PapersPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A|Science|2021|364